Dr. Paul Mason on LDL: Particle Count, Damage, and Risk
Dr. Paul Mason on LDL: Why the Usual Story Doesn’t Add Up
Affiliate Disclosure:
Some links on Vegans Are Delicious may be affiliate links, which means we may earn a commission at no extra cost to you. We only recommend products and resources we genuinely believe add value.
About Paul Mason, MD
Dr. Paul Mason is an Australian physician known for deep, evidence-heavy lectures on metabolic health and cardiovascular risk—especially where mainstream narratives get shaky. His work often focuses on lipid markers, insulin resistance, inflammation, and the difference between correlation and causation in nutrition science.
The LDL “Lipid Hypothesis” — and Why It Became the Default
For decades, many people were taught a simple story:
Eat fat → LDL goes up → arteries clog → heart disease.
Dr. Mason argues this “lipid hypothesis” didn’t win because it was proven beyond doubt — it won because it became culturally and medically entrenched, especially after high-profile events like President Eisenhower’s heart attack in 1955.
His main point: once a narrative becomes the official story, it can persist for generations even when contradictory evidence stacks up.
Watch the Original Video
Dr. Mason walks through the science, the lipoproteins, and the “LDL confusion” in full detail here:
👉 Watch the full video here:
(This article summarizes and discusses key points from the video for educational purposes.)
Key Takeaways (Mason’s Main Points)
LDL is a lipoprotein particle, not the same thing as “cholesterol”
Finding LDL inside plaque doesn’t prove LDL caused the plaque
LDL comes in different forms; small, dense (damaged) LDL is the bigger concern
Particle number (ApoB / LDL-P) can matter more than LDL-C volume
Triglycerides and HDL (and their ratio) can help predict risk patterns
Extremely high LDL may sometimes be a signal of other issues worth investigating (inflammation, B12 deficiency, etc.)
(This is a discussion of Dr. Mason’s lecture, not personal medical advice.)
LDL Isn’t “Cholesterol With a Mustache”
One of Mason’s biggest clarifications is that LDL is not simply “cholesterol.”
LDL is a lipoprotein — a transport particle made of:
fats (lipids),
cholesterol,
and proteins.
It carries cholesterol as cargo. But LDL itself is a complex structure with a job: deliver lipids to tissues and then return to the liver for recycling.
So when people treat “LDL” and “cholesterol” like interchangeable words, Mason argues they’re already off track.
Correlation Isn’t Causation (Guilt by Association Problem)
Mason points out that LDL and cholesterol can appear in atherosclerotic plaques — but that’s not proof they caused them.
His argument:
Two things being found together doesn’t automatically mean one created the other. That’s correlation, not causation.
He frames this as a classic “guilt by association” mistake.
LDL Is Part of a Conveyor Belt: VLDL → IDL → LDL
Mason explains that LDL doesn’t just “spawn” in the body as a villain.
It’s the end stage of a normal process:
the liver produces VLDL,
it delivers lipid cargo and shrinks into IDL,
then shrinks further into LDL,
and LDL is later taken back up by the liver for recycling.
He uses a helpful mental image: LDL is like a balloon with a slow leak—shrinking as it does its job.
“Dietary Cholesterol and Saturated Fat Raise LDL” — Mason Challenges This
Mason disputes the idea that dietary cholesterol and saturated fat automatically raise LDL in a meaningful way.
He argues that LDL levels are more influenced by factors like:
how much VLDL the liver is producing,
and how well particles are being cleared back into the liver.
(He highlights trials in the lecture to illustrate that real-world LDL response isn’t as simple as “eat fat = LDL rises.”)
The Big Pivot: Particle Count vs Particle Volume
This is where Mason gets spicy (in a good way).
He argues that LDL-C (the cholesterol amount inside LDL particles) can be less informative than:
LDL particle number (LDL-P) and/or
ApoB (the identifying protein on these particles)
Why? Because you can have:
many small particles (higher risk pattern)
without necessarily having massive LDL-C volume.
So Mason emphasizes: number of particles can matter more than the “amount of cholesterol.”
The “Damaged LDL” Idea: Small Dense LDL
Mason describes a concept that helps reconcile confusion:
Not all LDL is the same.
Larger, “buoyant” LDL patterns may not track with increased risk in the same way.
Small, dense LDL is treated as the more concerning pattern in many research discussions.
He explains that “damage” changes LDL behavior, and that’s what drives risk—not simply “LDL existing.”
Simple Clues You Can Get From a Standard Lipid Panel
Mason argues that even without expensive subfraction testing, you can estimate risk patterns using markers many people already have:
Triglycerides
Higher triglycerides correlate with greater likelihood of a small-dense LDL pattern.
HDL
Higher HDL is generally associated with more favorable patterns.
Triglycerides-to-HDL Ratio
He describes this ratio as a practical “signal” for whether the overall lipid pattern is more likely to be atherogenic (artery-clogging) or not.
(Important: this is not personalized medical guidance—just summarizing the lecture framework.)
A Nuanced Ending: Not All LDL Elevation Is “Good”
Mason does not claim every elevated LDL is automatically benign.
He flags that very high LDL can sometimes reflect:
insulin resistance (sometimes tied to high dairy intake in some contexts),
inflammation,
B12 deficiency,
thyroid/kidney issues,
medication effects,
or other factors.
His point: if LDL is unexpectedly high, don’t panic—but don’t ignore it either. Investigate context.
Related Reads on Vegans Are Delicious
🐄 Patty Prime’s Take 🥩
LDL got cast as the villain because it showed up at the scene of the crime. Dr. Mason’s whole lecture is basically: “Cool… but was it holding the knife?”-Patty Prime
